In-depth Research Report of Global RNAi for Therapeutic Market (2019 Version)


Report ID : RC-8410 Category : Pharmaceuticals Published Date : 15-Feb-19
Publisher : Lilan-Data-Info Pages : 126 Format : PDF
The Report mainly includes sales, revenue, trade, competition, investment, forecast and marketing of the product and the segments here include companies, types, applications, regions, countries, etc. 

The Global  market of RNAi for Therapeutic is expected to grow at a CAGR of roughly  over the next five years, will reach  million US$ in 2023, from  million US$ in 2017, according to a new LDI (Lilan Data & Info) study.

The regions of RNAi for Therapeutic contain all Global  market, especially in North America, Europe, Asia Pacific, Latin America and MEA. 

Players include Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, Quark Pharmaceuticals, RXi Pharmaceuticals, miRagen Therapeutics, Gradalis, Sirnaomics, etc.

Types cover siRNA, miRNA, shRNA, etc. and applications cover Cancer, Cardiovascular, HBV, Others, etc.

There are 11 Chapters to deeply display the global RNAi for Therapeutic market.
Chapter 1, is  definition and segment of RNAi for Therapeutic;
Chapter 2, is executive summary of RNAi for Therapeutic Market;
Chapter 3, to explain the industry chain of RNAi for Therapeutic;
Chapter 4, to show info and data comparison of  RNAi for Therapeutic Players;
Chapter 5, to show comparison of types;
Chapter 6, to show comparison of applications;
Chapter 7, to show comparison of regions and coutries(or sub-regions);
Chapter 8, to show competition and trade situation of RNAi for Therapeutic Market;
Chapter 9, to forecast RNAi for Therapeutic market in the next years;
Chapter 10, to show investment of RNAi for Therapeutic Market;
Table of Contents

Chap. 1, Definition and Segment
    1.1, Definition
    1.2, Segments
        A, Type Segment
        B, Application Segment
        C, Regional Segment

Chap. 2, Executive Summary of RNAi for Therapeutic Market

Chap. 3, Industrial Chain Analysis of RNAi for Therapeutic Market
    3.1, Industrial Chain of RNAi for Therapeutic
    3.2, Production Process of RNAi for Therapeutic
    3.3, Upstream and Cost of RNAi for Therapeutic
        A, Raw Materials Cost
        B, Equipment Market
        C, Labor Cost Analysis
        D, Cost Structure Analysis
    3.4, Distribution
        A, Marketing Channel
        B, Distributors/Agents
    3.5, Downstream

Chap. 4, Comparison of Companies
    4.1, Comprehensive Analysis of RNAi for Therapeutic Companies
        4.1.1, Business Comparison of Companies
        4.1.2, RNAi for Therapeutic Business Distribution by Companies
        4.1.3, RNAi for Therapeutic Product Comparison by Companies
    4.2, RNAi for Therapeutic Sales and Revenue by Companies
    4.3, Data Details (Sales, Revenue, Price, Share, Growth Rate, Gross Margin) Analysis of RNAi for Therapeutic by Companies
        Comp. 1: Data Details (Sales, Revenue, Price, Share, Growth Rate, Gross Margin) of Alnylam Pharmaceuticals
        Comp. 2: Data Details of Arrowhead
        Comp. 3: Data Details of Dicerna Pharmaceuticals
        Comp. 4: Data Details of Mirna Therapeutics
        Comp. 5: Data Details of Quark Pharmaceuticals
        Comp. 6: Data Details of RXi Pharmaceuticals
        Comp. 7: Data Details of miRagen Therapeutics
        Comp. 8: Data Details of Gradalis
        Comp. 9: Data Details of Sirnaomics

Chap. 5, Comparison of Types (Sales, Revenue, Share, Price, Growth)
    5.1, siRNA
    5.2, miRNA
    5.3, shRNA

Chap. 6, Comparison of Applications (Sales, Share, Growth)
    6.1, Cancer
    6.2, Cardiovascular
    6.3, HBV
    6.4, Others

Chap. 7, Comparison of Regions (Sales, Price, Revenue, Share, Growth)
    7.1, North America
        7.1.1, Sub-regions of North America
        7.1.2, U.S.A.
        7.1.3, Canada
    7.2, Europe
        7.2.1 Sub-regions of Europe
        7.2.2, Germany
        7.2.3, U.K.
        7.2.4, France
        7.2.5, Italy
        7.2.6, Spain
    7.3, Asia Pacific
        7.3.1, Sub-regions of Asia Pacific
        7.3.2, China
        7.3.3, India
        7.3.4, Japan
        7.3.5, Oceania
        7.3.6, SEA
    7.4, Latin America
        7.4.1, Sub-regions of Latin America
        7.4.2, Brazil
        7.4.3, Mexico
    7.5, MEA
        7.5.1, Sub-regions of MEA
        7.5.2, Mid-east
        7.5.3, South Africa

Chap. 8, Competition and Trade Situation Analysis of RNAi for Therapeutic Market
    8.1, Competition Situation by Players
        8.1.1, Market Concentration by Players
        8.1.2, Mergers & Acquisitions, Expansions
        8.1.3, New Entrants
    8.2, Competition Situation by Regions
    8.3, Trade Situation by Regions
        8.3.1, Trade Data (Import and Export) of North America
        8.3.2, Trade Data of Europe
        8.3.3, Trade Data of Asia Pacific
        8.3.4, Trade Data of Latin America
        8.3.5, Trade Data of MEA

Chap. 9, Forecast of RNAi for Therapeutic Market
    9.1, Market Size Forecast
        9.1.1, Opportunity
        9.1.2, Restraints
        9.1.3, Market Trend (Sales, Revenue)
    9.2, Types Forecast (Sales, Revenue)
    9.3, Application Forecast (Sales)
    9.4, Regional Forecast (Sales, Revenue)

Chap. 10, Investment Analysis of RNAi for Therapeutic Market
    10.1, Investment Opportunity
    10.2, Investment Calculation
        10.2.1, Cost Calculation
        10.2.2, Revenue Calculation
        10.2.3, Economic Performance Evaluation

Chap. 11, Appendix (Free Info)
    11.1, Profiles and RNAi for Therapeutic Product Information of Key Companies
        Comp. 1: (Profiles and RNAi for Therapeutic Product Information of) Alnylam Pharmaceuticals
        Comp. 2: Arrowhead
        Comp. 3: Dicerna Pharmaceuticals
        Comp. 4: Mirna Therapeutics
        Comp. 5: Quark Pharmaceuticals
        Comp. 6: RXi Pharmaceuticals
        Comp. 7: miRagen Therapeutics
        Comp. 8: Gradalis
        Comp. 9: Sirnaomics
    11.2, Contact Info of Related Companies
    11.3, Assumptions and Research Methodology
    11.4, Average Annual Exchange Rate
    11.5, Global and Regional Economic Change
    11.6, Global and Regional Labor Cost Index
    11.7, Relevant Policy (Examples)
    11.8, Relevant Patent and Technological Innovation (Examples)
    11.9, Info & Data Source
    11.10, Details of Abbreviated Words
    11.11, Disclaimer
    11.12, Author List

Sidebar Menu